Cargando…

Integrating Cell-Based and Clinical Genome-Wide Studies to Identify Genetic Variants Contributing to Treatment Failure in Neuroblastoma Patients

High-risk neuroblastoma is an aggressive malignancy with high rates of treatment failure. We evaluated genetic variants associated with in vitro sensitivity to two derivatives of cyclophosphamide for association with clinical response in a separate replication cohort of neuroblastoma patients (n=2,7...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinto, Navin, Gamazon, Eric R., Antao, Nirav, Myers, Jamie, Stark, Amy L., Konkashbaev, Anuar, Im, Hae Kyung, Diskin, Sharon J., London, Wendy B., Ludeman, Susan M., Maris, John M., Cox, Nancy J., Cohn, Susan L., Dolan, M. Eileen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029857/ https://www.ncbi.nlm.nih.gov/pubmed/24549002 http://dx.doi.org/10.1038/clpt.2014.37

Ejemplares similares

SCAN database: facilitating integrative analyses of cytosine modification and expression QTL
por: Zhang, Wei, et al.
Publicado: (2015)

Mixed Effects Modeling of Proliferation Rates in Cell-Based Models: Consequence for Pharmacogenomics and Cancer
por: Im, Hae Kyung, et al.
Publicado: (2012)

Evidence of selection on splicing-associated loci in human populations and relevance to disease loci mapping
por: Gamazon, Eric R., et al.
Publicado: (2017)

Integrative Genomics: Quantifying Significance of Phenotype-Genotype Relationships from Multiple Sources of High-Throughput Data
por: Gamazon, Eric R., et al.
Publicado: (2013)

Protein Quantitative Trait Loci Identify Novel Candidates Modulating Cellular Response to Chemotherapy
por: Stark, Amy L., et al.
Publicado: (2014)

ExprTarget: An Integrative Approach to Predicting Human MicroRNA Targets
por: Gamazon, Eric R., et al.
Publicado: (2010)

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
por: Ambros, P F, et al.
Publicado: (2009)

Comprehensive Survey of SNPs in the Affymetrix Exon Array Using the 1000 Genomes Dataset
por: Gamazon, Eric R., et al.
Publicado: (2010)

Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial
por: de Alarcon, Pedro A., et al.
Publicado: (2017)

Genome-Wide Local Ancestry Approach Identifies Genes and Variants Associated with Chemotherapeutic Susceptibility in African Americans
por: Wheeler, Heather E., et al.
Publicado: (2011)

Association Between Participation in Clinical Trials and Overall Survival Among Children With Intermediate- or High-risk Neuroblastoma
por: Balyasny, Skye, et al.
Publicado: (2021)

Copy number polymorphisms and anticancer pharmacogenomics
por: Gamazon, Eric R, et al.
Publicado: (2011)

Trait-Associated SNPs Are More Likely to Be eQTLs: Annotation to Enhance Discovery from GWAS
por: Nicolae, Dan L., et al.
Publicado: (2010)

Identification and Validation of Genetic Variants that Influence Transcription Factor and Cell Signaling Protein Levels
por: Hause, Ronald J., et al.
Publicado: (2014)

WANTED: Better neuroblastoma biomarkers and better stratification
por: London, Wendy B.
Publicado: (2022)

Epigenomic profiling of neuroblastoma cell lines
por: Upton, Kristen, et al.
Publicado: (2020)

A Pilot Study of Tandem High Dose Chemotherapy with Stem Cell Rescue as Consolidation for High Risk Neuroblastoma: Children’s Oncology Group study ANBL00P1
por: Seif, Alix E., et al.
Publicado: (2013)

Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for Neuroblastoma
por: Yagyu, Shigeki, et al.
Publicado: (2016)

Genome-wide Meta-analysis Identifies Variants Associated with Platinating Agent Susceptibility Across Populations
por: Wheeler, Heather E., et al.
Publicado: (2011)

EPS8 Inhibition Increases Cisplatin Sensitivity in Lung Cancer Cells
por: Gorsic, Lidija K., et al.
Publicado: (2013)

Composite tumor with pheochromocytoma and immature neuroblastoma: report of two cases with cytogenetic analysis and discussion of current terminology
por: Tran, Lily, et al.
Publicado: (2017)

ABCC Multidrug Transporters in Childhood Neuroblastoma: Clinical and Biological Effects Independent of Cytotoxic Drug Efflux
por: Henderson, Michelle J., et al.
Publicado: (2011)

Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study
por: Wang, L L, et al.
Publicado: (2015)

Establishment of CYP2D6 Reference Samples by Multiple Validated Genotyping Platforms
por: Fang, Hua, et al.
Publicado: (2014)

Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project
por: Schleiermacher, G, et al.
Publicado: (2012)

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma
por: Capasso, Mario, et al.
Publicado: (2009)

MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children’s oncology group
por: Niemas-Teshiba, Risa, et al.
Publicado: (2017)

Evaluation of Norepinephrine Transporter Expression and Metaiodobenzylguanidine Avidity in Neuroblastoma: A Report from the Children's Oncology Group
por: DuBois, Steven G., et al.
Publicado: (2012)

Variants Affecting Exon Skipping Contribute to Complex Traits
por: Lee, Younghee, et al.
Publicado: (2012)

BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma
por: Randall, Michael P., et al.
Publicado: (2023)

CHD5, a Tumor Suppressor Gene Deleted From 1p36.31 in Neuroblastomas
por: Fujita, Tomoyuki, et al.
Publicado: (2008)

Presence Of Cancer-Associated Fibroblasts Inversely Correlates With Schwannian Stroma In Neuroblastoma Tumors
por: Zeine, Rana, et al.
Publicado: (2009)

Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors
por: Chlenski, Alexandre, et al.
Publicado: (2010)

Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines
por: Yang, Qiwei, et al.
Publicado: (2010)

Gene and MicroRNA Perturbations of Cellular Response to Pemetrexed Implicate Biological Networks and Enable Imputation of Response in Lung Adenocarcinoma
por: Gamazon, Eric R., et al.
Publicado: (2018)

Immunogenomic determinants of tumor microenvironment correlate with superior survival in high-risk neuroblastoma
por: Bao, Riyue, et al.
Publicado: (2021)

Germline pathogenic variants in 786 neuroblastoma patients
por: Kim, Jung, et al.
Publicado: (2023)

Somatic structural variation targets neurodevelopmental genes and identifies SHANK2 as a tumor suppressor in neuroblastoma
por: Lopez, Gonzalo, et al.
Publicado: (2020)

The genetic landscape of high-risk neuroblastoma
por: Pugh, Trevor J., et al.
Publicado: (2013)

Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma
por: Diskin, Sharon J, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_f99ndtfi6qh30af3b19u6g0do1